Lise Lund Kjems is Chief Medical Officer of Cyclo Therapeutics, Inc.. Currently has a direct ownership of 17,053 shares of CYTH, which is worth approximately $11,425. The most recent transaction as insider was on Sep 27, 2021, when has been sold 17,053 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.1K
0% 3M change
0% 12M change
Total Value Held $11,425

Lise Lund Kjems Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 27 2021
BUY
Grant, award, or other acquisition
-
17,053 Added 50.0%
17,053 Common Stock
LLK

Lise Lund Kjems

Chief Medical Officer
Concord, MA

Track Institutional and Insider Activities on CYTH

Follow Cyclo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTH shares.

Notify only if

Insider Trading

Get notified when an Cyclo Therapeutics, Inc. insider buys or sells CYTH shares.

Notify only if

News

Receive news related to Cyclo Therapeutics, Inc.

Track Activities on CYTH